IN8BIO, INC. Common Stock, Capital Shares Reserved for Future Issuance
IN8BIO, INC. (INAB) had Common Stock, Capital Shares Reserved for Future Issuance of 4.05 million shares as of 2023-06-15, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2023-06-15: Common Stock, Capital Shares Reserved for Future Issuance 4.05M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 246.67K shares.
- 2021-07-29: Common Stock, Capital Shares Reserved for Future Issuance 6.67K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2023-06-15 | 4.05M shares 10-Q · filed 2026-08-06 | 246.67K shares 10-Q · filed 2025-08-07 |
| 2021-07-29 | 6.67K shares 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |